← back to search

Alison Edelman

UC Davis Health System · US
Area of research
Public Health, Environmental and Occupational Health · Pediatrics, Perinatology and Child Health
Research interest
Research interests include Reproductive Health and Contraception, Ovarian function and disorders, Global Maternal and Child Health, and Maternal and fetal healthcare.
h-index
41
citations
5,960
works
348
NIH funding
primary concept
Medicine
email

Recent publications

Treatment of unfavorable bleeding patterns in contraceptive implant users with tranexamic acid: randomized clinical trial.
2026cited by 0position: contributordoi
Menstrual cycle patterns during acute and long COVID-19 infection among a cohort of individuals with regular menstrual cycles.
2026cited by 0position: contributordoi
The emerging role of progesterone receptor modulators in breast physiology, cancer prevention and treatment.
2026cited by 0position: contributordoi
Association between menstrual cycle pattern regularity and changes in menstrual bleeding following COVID-19 vaccination: secondary analysis of an observational study.
2026cited by 0position: contributordoi
Double dosing ulipristal acetate emergency contraception for individuals with obesity: a randomised crossover trial.
2025cited by 2position: contributordoi
Sexual and reproductive health clinical consultations: breastfeeding and progestogen-only contraception.
2025cited by 1position: contributordoi
Reusable menstrual hygiene products may lead to underdiagnosis of heavy menstrual bleeding: a randomised trial.
2025cited by 0position: contributordoi
Menstrual cycle phase and its association with COVID-19 vaccine side effects and subsequent infection: A study of period tracking app users
2025cited by 0position: contributordoi
Local anaesthesia for pain control in surgical abortion before 14 weeks of pregnancy: a systematic review.
2025cited by 0position: contributordoi
Association between COVID-19 vaccination and menstruation: a state of the science review
BMJ Sexual & Reproductive Health 2024cited by 16position: lastdoi
Emergency contraception for individuals weighing 80 kg or greater: A randomized trial of 30 mg ulipristal acetate and 1.5 mg or 3.0 mg levonorgestrel.
2024cited by 6position: contributordoi
Timing of COVID19 vaccination drives menstrual cycle changes
2023cited by 0position: contributordoi
Association between menstrual cycle length and covid-19 vaccination: global, retrospective cohort study of prospectively collected data.
2022cited by 60position: contributordoi
Heavy menstrual bleeding in women on oral anticoagulants.
2021cited by 23position: contributordoi
Association of pharmacist prescription and 12-month contraceptive continuation rates.
2021cited by 7position: contributordoi
Medical abortion offered in pharmacy versus clinic-based settings: A systematic review.
2021cited by 5position: contributordoi
Abortion Care Beyond 13 Weeks' Gestation: A Global Perspective.
2021cited by 3position: contributordoi
Controversies in family planning: Management of cesarean-scar ectopic pregnancy.
2021cited by 3position: contributordoi
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study.
2021cited by 2position: contributordoi
Addressing the urgent global need for later abortion care during COVID-19 and beyond.
2021cited by 1position: contributordoi
Medical abortion offered in pharmacy versus clinic-based settings.
2021cited by 1position: contributordoi
Cochrane Review Summaries-April 2021.
2021cited by 0position: contributordoi
Assessing the Pregnancy Protective Impact of Scheduled Nonadherence to a Novel Progestin-Only Pill: Protocol for a Prospective, Multicenter, Randomized, Crossover Study (Preprint)
2021cited by 0position: contributordoi
Association of Pharmacist Prescription With Dispensed Duration of Hormonal Contraception.
2020cited by 33position: contributordoi
Reasons for and experience in obtaining pharmacist prescribed contraception.
2020cited by 20position: contributordoi
Reproductive services for women at high risk for maternal mortality: a report of the workshop of the Society for Maternal-Fetal Medicine, the American College of Obstetricians and Gynecologists, the Fellowship in Family Planning, and the Society of Family Planning.
2020cited by 20position: contributordoi
Best Practices for Counseling Adolescents about the Etonogestrel Implant.
2020cited by 18position: contributordoi
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Environmental Contamination and Childbirth.
2020cited by 15position: contributordoi
Treatment of Unfavorable Bleeding Patterns in Contraceptive Implant Users: A Randomized Controlled Trial.
2020cited by 15position: contributordoi
Expanding Access to Comprehensive Abortion Care in Humanitarian Contexts: Case Study from the Rohingya Refugee Camps in Bangladesh.
2020cited by 11position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 17 papers (2020–2026)Emily Boniface · Oregon Health & Science University4 papers (2023–2026)Jeffrey T. Jensen · Oregon National Primate Research Center4 papers (2020–2020) · 3 papers (2020–2026)Mitchell D. Creinin · Northwestern University2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2025–2026) · 2 papers (2020–2025)Pascale Borensztein · HRA Pharma SA2 papers (2021–2021) · 2 papers (2020–2020)Anna Glasier · University of Edinburgh2 papers (2021–2021)Agnes Hemon · HRA Pharma (France)2 papers (2021–2021)Nathalie Kapp · International Planned Parenthood Federation1 papers (2021–2021) · 1 papers (2013–2013)Leo Han · Oregon National Primate Research Center1 papers (2019–2019)Leo Han · 1 papers (2019–2019)Eva Patil · Linköping University1 papers (2020–2020)Christian M. Pettker · University of Iowa1 papers (2020–2020)Sarah Walters · University of Cambridge1 papers (2025–2025)Sharon T Cameron · NHS Lothian1 papers (2026–2026)